Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AZN – AstraZeneca PLC

Astrazeneca PLC
AZN
$72.85
Name : Astrazeneca PLC
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $227,370,680,320.00
EPSttm : 2.48
finviz dynamic chart for AZN
Astrazeneca PLC
$72.85
0.69%
$0.5

Float Short %

0.24

Margin Of Safety %

4

Put/Call OI Ratio

0.35

EPS Next Q Diff

-0.13

EPS Last/This Y

2.24

EPS This/Next Y

0.55

Price

72.35

Target Price

92.38

Analyst Recom

1.35

Performance Q

-6.61

Relative Volume

0.7

Beta

0.39

Ticker: AZN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-07AZN70.090.370.42160495
2025-05-08AZN67.290.370.38165508
2025-05-09AZN67.560.361.18180983
2025-05-12AZN68.940.390.71179065
2025-05-13AZN67.730.400.38181914
2025-05-14AZN66.240.390.52185622
2025-05-15AZN67.970.400.47184576
2025-05-16AZN68.80.380.52190842
2025-05-19AZN69.70.380.58156660
2025-05-20AZN69.920.380.19159579
2025-05-21AZN69.670.360.26172350
2025-05-22AZN69.940.360.84172834
2025-05-23AZN70.410.360.71173629
2025-05-27AZN70.960.360.93170856
2025-05-28AZN70.390.361.79171863
2025-05-29AZN70.880.360.06172732
2025-05-30AZN72.820.340.14180819
2025-06-02AZN71.930.340.15176926
2025-06-03AZN71.860.330.32184803
2025-06-04AZN730.350.34185493
2025-06-05AZN72.360.350.55185543
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-07AZN70.0715.34485.54.51
2025-05-08AZN67.3015.34126.14.51
2025-05-09AZN67.5715.34735.94.51
2025-05-12AZN68.9515.34963.14.51
2025-05-13AZN67.7215.34640.04.51
2025-05-14AZN66.2315.34573.64.51
2025-05-15AZN67.9515.35016.14.51
2025-05-16AZN68.7715.35060.34.51
2025-05-19AZN69.6915.34943.74.51
2025-05-20AZN69.9215.35015.54.51
2025-05-21AZN69.6715.34762.94.51
2025-05-22AZN69.9215.34813.04.51
2025-05-23AZN70.4315.34913.34.51
2025-05-27AZN70.9615.34934.64.51
2025-05-28AZN70.3915.34622.54.51
2025-05-29AZN70.8815.34904.84.51
2025-05-30AZN72.8315.35365.44.51
2025-06-02AZN71.9315.34681.94.51
2025-06-03AZN71.8215.34697.94.51
2025-06-04AZN73.0015.34991.24.51
2025-06-05AZN72.3515.34722.24.51
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-07AZN0.00-1.590.20
2025-05-08AZN0.00-1.590.20
2025-05-09AZN0.00-1.590.20
2025-05-12AZN0.00-1.610.16
2025-05-13AZN0.00-1.610.16
2025-05-14AZN0.00-1.610.16
2025-05-15AZN0.00-1.610.16
2025-05-16AZN0.00-1.610.16
2025-05-19AZN0.00-1.520.16
2025-05-20AZN0.00-1.520.16
2025-05-21AZN0.00-1.520.16
2025-05-22AZN0.00-1.520.16
2025-05-23AZN0.00-1.520.16
2025-05-27AZN0.000.570.16
2025-05-28AZN0.000.570.24
2025-05-29AZN0.000.570.24
2025-05-30AZN0.000.570.24
2025-06-02AZN0.000.590.24
2025-06-03AZN0.000.590.24
2025-06-04AZN0.000.590.24
2025-06-05AZN0.000.590.24
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

1.24

Avg. EPS Est. Current Quarter

1.14

Avg. EPS Est. Next Quarter

1.11

Insider Transactions

Institutional Transactions

0.59

Beta

0.39

Average Sales Estimate Current Quarter

14079

Average Sales Estimate Next Quarter

14571

Fair Value

75.06

Quality Score

93

Growth Score

95

Sentiment Score

72

Actual DrawDown %

17.5

Max Drawdown 5-Year %

-27.9

Target Price

92.38

P/E

29.07

Forward P/E

14.22

PEG

2.6

P/S

4.08

P/B

5.47

P/Free Cash Flow

19.56

EPS

2.49

Average EPS Est. Cur. Y​

4.51

EPS Next Y. (Est.)

5.05

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

14.14

Relative Volume

0.7

Return on Equity vs Sector %

-5.1

Return on Equity vs Industry %

-13.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.09

EBIT Estimation

4722.2
Astrazeneca PLC
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 94300
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, Byetta, XIGDUO, Accolate, Accoleit, Vanticon, Beyfortus, Synagis, FluMist, tixagevimab and cilgavimab, and sipavibart. It also provides Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Bricanyl Turbuhaler, Rhinocort, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Breztri Aerosphere, Duaklir Genuair, Kavigale, Evusheld, Fluenz/FluMist, and Voydeya. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the United States, Europe, and Asia. It has a strategic agreement with Tempus to develop the largest multimodal foundation model in oncology. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
stock quote shares AZN – AstraZeneca PLC Stock Price stock today
news today AZN – AstraZeneca PLC stock forecast ,stock prediction 2023 2024 2025
marketwatch AZN – AstraZeneca PLC yahoo finance google finance
stock history AZN – AstraZeneca PLC invest stock market
stock prices AZN premarket after hours
ticker AZN fair value insiders trading